Vaidyanathan Subramaniam,  —

Recent Posts

• Takeda acquires license to ALS therapy aimed at toxic TDP-43
• Living with ALS means unraveling my concept of time
• Trial of brain-computer interface device for ALS now enrolling
• PrimeC, potential ALS therapy, earns patents in Europe, Japan, Israel
• FDA advisory committee votes against NurOwn approval for ALS